BMRN vs SOFI · P/E 40, rev $1.76B vs P/E 39, rev $283.1M
Biomarin Pharmaceutical Inc (BMRN) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported SOFI revenue for 2026-06-30 was $283.1M. Net income was $323.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the BMRN and SOFI stock pages for the full models.
Not investment advice.